Sequana Medical

IFBC was mandated by Sequana as an independent advisor to determine the value of the employee stock options for recognition in the financial statements. The challenge was in particular to correctly take into account the share classes and liquidity preferences that existed due to several financing rounds. Sequana AG is a commercial stage medical device company focused on innovative treatment solutions for liver disease, heart failure, malignant ascites and other fluid imbalance disorders.